FXR1 copy number gain occurs in some types of cancers, particularly in lung squamous carcinoma (Comtesse et al., 2007; Qian et al., 2015) and its occurrence is mutually exclusive with TP53 and FXR2 homozygous deletion according to TCGA database (Figure 1A). This evidence concerns the gene TP53 and cancer.